NCT06277947 2024-02-26
GARD-HIPEC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Unknown
Clinical Trials
47 trialsNCT05212779 2024-02-01
Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Unknown
NCT05489926 2024-01-26
A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT06223763 2024-01-25
SUROVA
Clinica Universidad de Navarra, Universidad de Navarra
Unknown
NCT06085456 2023-10-17
Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study
RenJi Hospital
Unknown
NCT05272462 2023-10-05
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer
Loyola University
Phase 2 Unknown
NCT05856409 2023-08-16
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
RenJi Hospital
Unknown
NCT05874115 2023-08-03
OutCoME
Centro di Riferimento Oncologico - Aviano
Unknown
NCT05877911 2023-05-26
Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT04670978 2023-04-25
Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer
Shandong University
Phase 2 Unknown
NCT03321188 2023-02-06
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
University of Kansas Medical Center
Phase 2 Unknown
NCT04015739 2022-08-17
BOLD
ARCAGY/ GINECO GROUP
Phase 2 Unknown
NCT03794778 2022-07-18
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 4 Unknown
NCT04864431 2022-06-22
VitD
Indonesia University
Phase NA Unknown
NCT05422183 2022-06-16
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer
Zhongda Hospital
Phase 2 Unknown
NCT05158062 2022-04-26
Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer
Saitama Medical University International Medical Center
Phase 2 Unknown
NCT05310357 2022-04-04
Chromosomal Instability in Ovarian Cancer
Peking Union Medical College Hospital
Unknown
NCT05310370 2022-04-04
HRD and Resistance to PAPPi in EOC Patients
Peking Union Medical College Hospital
Unknown
NCT05187208 2022-01-26
POLO
Seoul National University Hospital
Phase 4 Unknown
NCT04620954 2021-12-01
ORION-02
National Cancer Centre, Singapore
Phase 1/2 Unknown
NCT04885270 2021-08-10
Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer
West China Second University Hospital
Phase 3 Unknown
NCT02822157 2021-01-29
CLIO
Universitaire Ziekenhuizen KU Leuven
Phase 2 Unknown
NCT04651933 2020-12-04
A Training Set for the HRD Model in EOC
Peking Union Medical College Hospital
Unknown
NCT04651946 2020-12-03
Cell-free DNA Methylation for Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04566952 2020-10-30
ANLOLA
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04279509 2020-09-09
Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)
National University Hospital, Singapore
Phase NA Unknown
NCT04473339 2020-09-09
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation
Zhongnan Hospital
Phase 3 Unknown
NCT04504110 2020-08-10
68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03371693 2020-05-29
HIPECOV
Zhongnan Hospital
Phase 3 Unknown
NCT03349463 2020-02-28
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
Loyola University
Phase 4 Unknown
NCT04191252 2019-12-20
Genetic Mutation in Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Unknown
NCT04190667 2019-12-10
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Unknown
NCT03373058 2019-11-06
EHTASEOCCS
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Unknown
NCT04101760 2019-10-08
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT03742388 2018-11-15
A Genomic Analysis of Evolution of Epithelia Ovarian Tumors
Peking Union Medical College Hospital
Unknown
NCT03742856 2018-11-15
A Multi-omics Study of Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Unknown
NCT03015376 2018-11-14
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Unknown
NCT03740464 2018-11-14
Long-acting G-CSF for Febrile Neutropenia
Peking Union Medical College Hospital
Phase 3 Unknown
NCT02981901 2018-08-23
Ovaire01
Centre Leon Berard
Unknown
NCT03180177 2018-01-24
EHNPCTASEOC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Unknown
NCT01680575 2017-05-31
Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
Asan Medical Center
Unknown
NCT02437812 2017-02-28
Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma
Gynecologic Oncology Associates
Phase 2 Unknown
NCT00553683 2014-01-14
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Rutgers, The State University of New Jersey
Phase 1/2 Unknown
NCT00039559 2013-06-10
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
Massachusetts General Hospital
Phase NA Unknown
NCT01456065 2013-03-01
Safety of Active Immunotherapy in Subjects With Ovarian Cancer
Life Research Technologies GmbH
Phase 1 Unknown
NCT00715286 2008-07-15
Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study
All India Institute of Medical Sciences
Phase 3 Unknown
NCT00349505 2006-10-06
Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Unknown